コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 supported by a dedicated experimental large animal study.
2 n used to identify the parameters for a live animal study.
3 Experimental animal study.
4 Interventional controlled experimental animal study.
5 Randomized animal study.
6 Prospective randomized ex vivo animal study.
7 essed this issue with a large interventional animal study.
8 0.8 V/m, the lower limit of effectiveness in animal studies.
9 proven effective at reducing fat storage in animal studies.
10 ficant difference in their effect in post-MI animal studies.
11 there is a lack of supporting evidence from animal studies.
12 t host environments can be better modeled in animal studies.
13 o ensure reproducibility in experimental and animal studies.
14 facilitate comparability of future human and animal studies.
15 Minor publication bias was observed in small animal studies.
16 nd optimization of stimulation parameters in animal studies.
17 ies and have not been reported in controlled animal studies.
18 olving concepts of NAFLD from both human and animal studies.
19 mental developmental principles learned from animal studies.
20 thus being a valid candidate for subsequent animal studies.
21 surements were made from phantom, human, and animal studies.
22 ure levels that are lower than those used in animal studies.
23 Finally, the system was successfully used in animal studies.
24 o findings from microelectrode recordings in animal studies.
25 ed the published data on PEP efficacy across animal studies.
26 ly connected to immune-mediated disorders in animal studies.
27 s reduced by deprivation, as demonstrated by animal studies.
28 be so much less invasive than they can be in animal studies.
29 fe support or hyperbaric oxygen therapy, and animal studies.
30 ere found to be compatible with results from animal studies.
31 een shown to be disrupted by cannabinoids in animal studies.
32 mph node transplant) to cover both human and animal studies.
33 l Animal Care and Use Committee approved all animal studies.
34 Most HAAs are carcinogenic in long-term animal studies.
35 lobin-based oxygen carrier (HBOC) in in vivo animal studies.
36 thropoietin promoted hepatic regeneration in animal studies.
37 lammatory effects in humans, as predicted by animal studies.
38 rs have shown promise in several preclinical animal studies.
39 It is also bioavailable and suitable for animal studies.
40 the ethical and technical reach permitted by animal studies.
41 od oral bioavailability were observed during animal studies.
42 ter tract in spatial learning, as implied by animal studies.
43 se of dose-response analyses in vitro and/or animal studies.
44 orting evidence, albeit largely derived from animal studies.
45 ip bias has not been examined in preclinical animal studies.
46 rm to atherosclerosis progression comes from animal studies.
47 n than currently modeled or measured in most animal studies.
48 ung protection seen in previous clinical and animal studies.
49 clinical trials and the other in preliminary animal studies.
50 comes has recently emerged from clinical and animal studies.
51 ed only after brain injury, causing edema in animal studies.
52 of experimental design and interpretation in animal studies.
53 issue inflammation and insulin resistance in animal studies.
54 and exceeding protective thresholds seen in animal studies.
55 onditioning and extinction in both human and animal studies.
56 its promising applications for live cell and animal studies.
57 g an experimentally tractable alternative to animal studies.
58 suggested to be embryotoxic and fetotoxic in animal studies.
59 in C-terminus are often used in cellular and animal studies.
60 l understood and rely mainly on experimental animal studies.
63 al stromal cells (MSCs) constitute, based on animal studies, a promising interventional strategy for
64 al research, both the sex and the age of the animals studied affect disease phenotypes by modifying t
69 s limited because it is derived largely from animal studies and analysis of human mononuclear phagocy
71 erception that fibrotic tissue is permanent, animal studies and clinical data now demonstrate the hig
72 cs shifted from one driven by discoveries in animal studies and clinical observations (eg, oestrogen,
75 ative (ADQI) XIII was to harmonize human and animal studies and determine what is known about potenti
76 ume of literature, comprising both human and animal studies and employing both observational and expe
78 xample, there is growing evidence, both from animal studies and from human neuroimaging, that activit
83 ss the lack of reproducibility in biomedical animal studies and improve the communication of research
88 sphenol A (BPA) show reproductive effects in animal studies and potentially affect human ovulation, c
91 lation in conditions of parental stress (one animal study and seven human studies) also reported incr
92 nociceptive processes (in line with previous animal studies); and the LC showing lateralized activity
93 e research designs and results obtained from animal studies, and compare these to the human trials.
100 is feasible and merits exploration in intact animal studies as an energy source for arrhythmia elimin
101 the pathophysiological literature, including animal studies, as well as experimental psychology and c
102 etimes show effects that are not observed in animal studies at human exposure levels that are lower t
103 h is bidirectional in nature, with human and animal studies becoming more closely integrated as techn
106 limus-coated balloons has been shown in few animal studies, but data from randomized clinical trials
107 -inflammatory functions in some clinical and animal studies, but the direct mechanism is not fully un
108 ics has been employed in a growing number of animal studies, but the technique has yet to be widely u
109 fied in the ES luminal epithelium, mainly in animal studies, but there has been no functional study i
110 ng and executive functions, and (4) show how animal studies can reveal population and network phenome
114 y 2015 under protocols approved by the local animal studies committee and institutional review board.
115 there is conflicting evidence from human and animal studies concerning the effects of THC on the dopa
117 A prospective comparative case - control animal study conducted on 56 eyes of 28 healthy new born
124 Human clinical studies as well as laboratory animal studies demonstrate that offspring of pregnancies
125 ss to offspring via early postnatal care, as animal studies demonstrate the importance of early mater
128 arize data from a diverse array of human and animal studies demonstrating that the vmPFC is a key nod
132 continued basic science, translational, and animal studies for providing mechanisms to explain causa
134 common to see contradictions of outcomes in animal studies from different research groups, leading t
139 onnectivity between these brain regions, and animal studies have demonstrated that the vmPFC modulate
147 icacy results from both in-vitro and in-vivo animal studies have led to their steady progression thro
153 patients with differing outcomes and use of animal studies have shed some light on this issue, but m
154 G toxicity have not been published, however, animal studies have shown FG or Geniposide can cause hep
164 of the post-translational modifications, and animal studies have suggested the involvement of IgG gly
167 of cannabis exposure, for which experimental animal studies have validated causal relationships betwe
169 dala is well established [4], both human and animal studies implicate other brain regions in learning
170 im of making remaining material derived from animal studies in biomedical research more visible and a
171 is notion has been supported by in-vitro and animal studies in bone, cartilage, tendon, and muscle.
172 e the importance of validating findings from animal studies in human brain tissue, and advocate for N
173 s orchestrate such timing as demonstrated by animal studies in vitro [3, 4] and in vivo [5, 6], sugge
174 this hypothesis is primarily on the basis of animal studies, in which the gene is inactivated simulta
175 rmacokinetic parameters suitable for in vivo animal studies, including low clearances and decent oral
176 t will enhance translation between human and animal studies, including the identification of intermed
180 diphenyl ethers (PBDEs) are limited despite animal studies indicating PBDEs' potential role as an ob
181 6 levels: in vitro characterization, in vivo animal studies, initial human studies, impact on clinica
182 e, and thus far the transfer of results from animal studies into successful clinical trials has been
183 ue in depth by conducting a meta-analysis of animal studies investigating the efficacy of the clinica
184 es by mimicking recent findings from in vivo animal studies involving intrastriatal administration of
186 , evidence from recent human and preclinical animal studies is reviewed, indicating that SPMs are phy
188 could be utilized both in human studies and animal studies, is needed to integrate the field truly.
190 and control patients confirmed results from animal studies (mean CNR for NASH vs control patients, 2
191 risk factor for hearing impairment, and, in animal studies, molecular evidence suggests a role for I
195 in rats, and 89% of human studies and 70% of animal studies of early-life adversity reported increase
197 Systematic consideration of experimental animal studies of oral biphenyl exposure took into accou
198 As a scientific case study, preclinical animal studies of these nutrients definitively influence
200 cupational and accidental exposure, only few animal studies on the genotoxic effects of chronic LDR r
201 l motor control, in close collaboration with animal studies on the molecular biology of the spinal co
202 rity, thereby providing clinical validity to animal studies on the role of platelets in severe infect
203 studies that presented preclinical in vivo (animal studies) or clinical (human studies) evidence for
204 FA) and the major SFA in the HFD used in our animal study-potently enhanced LPS-induced proinflammato
208 number of clinical reports and some critical animal studies regarding pre-existing and treatment-indu
210 ogy had less consistent results, with 67% of animal studies reporting increased exon 17 methylation a
213 ologies are becoming clearer, several recent animal studies revealed that short-term administration o
223 t acoustic temporal fine structure (TFS) and animal studies showing minimal changes in neural coding
224 These observations were confirmed by in vivo animal studies showing preferential recruitment of APCs
226 These results are consistent with those from animal studies showing that exposure to PBDEs is associa
235 arly correlate of disease later in life, and animal studies suggest that low birth weight is associat
240 well as propagation phase, and insights from animal studies suggest that targeting the IL-1 pathway c
246 D, recent evidence from human postmortem and animal studies suggests a selective vulnerability of GAB
249 rious ACE-Ang II-Ang II type 1 receptor arm, animal studies support the existence of protective amino
251 Although there are some in vitro and limited animal studies supporting these mechanisms, heme-mediate
254 traditional 2D cell cultures and preclinical animal studies that have historically been the standard
257 oral, and electrophysiological findings from animal studies that provide a new understanding on how M
258 or the theory is largely drawn from nonhuman animal studies that use invasive pharmacological or elec
259 ustry did not disclose evidence of harm from animal studies that would have (1) strengthened the case
260 pite its widespread application in human and animal studies, the neurobiological basis of fear condit
267 ransplantation has been demonstrated in many animal studies to cure experimentally induced diabetes.
269 ; 3) the shift from reliance on high-quality animal studies to define mechanisms that established the
270 es and mood, emotion, cognition, and memory; animal studies to determine epigenetic changes that repr
271 amine H1 receptor systems have been shown in animal studies to have important roles in the reversal o
272 on has to be exercised in the translation of animal studies to human beings, our data strongly sugges
274 take this into account when designing large animal studies to most closely mimic the clinical course
275 e results to data obtained from multispecies animal studies to provide a detailed example of translat
277 regarding the generalizability of controlled animal studies to the more multifaceted pattern of human
281 t, which has been rarely identified, even in animal studies, using electrophysiological/pharmacologic
296 he present review attempts to link human and animal studies while proposing molecular mechanisms that
297 ses cell proliferation, both in-vitro and in animal studies, while also demonstrates additive efficac
298 rting this hypothesis from human imaging and animal studies will be discussed, and combinatorial drug
299 a promise as a myelin biomarker in human and animal studies with a particular advantage of sensitivit
300 This evidence is primarily derived from animal studies, with limited study in humans due to inac
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。